m Personalized Medicine in Munich 4
... dressing the development of targeted therapies and orphan diseases, the high number of innovative small and medium-sized biotech enterprises in the Munich biotech region, with its close proximity to academia and both university hospitals, has the ideal prerequisites to strengthen the efforts towards ...
... dressing the development of targeted therapies and orphan diseases, the high number of innovative small and medium-sized biotech enterprises in the Munich biotech region, with its close proximity to academia and both university hospitals, has the ideal prerequisites to strengthen the efforts towards ...
chiropractic physiological therapeutics
... method: After washing and drying the extremity, dip the part in and out of the bath quickly, allow time between dipping for congealing, dip again, and keep repeating until the thickness of the paraffin is from 1/4 inch to 1/2 inch. Keep the fingers spread apart when dipping the hands. ...
... method: After washing and drying the extremity, dip the part in and out of the bath quickly, allow time between dipping for congealing, dip again, and keep repeating until the thickness of the paraffin is from 1/4 inch to 1/2 inch. Keep the fingers spread apart when dipping the hands. ...
Antimycobacterials
... 1. Isoniazid (INH), a synthetic analogue of pyridoxine, is the most potent tuberculocidal drug. It is an essential component of all regimens, unless the patients are not able to tolerate it or bacteria are resistant. INH is bactericidal for multiplying tubercle bacilli, but is less effective agains ...
... 1. Isoniazid (INH), a synthetic analogue of pyridoxine, is the most potent tuberculocidal drug. It is an essential component of all regimens, unless the patients are not able to tolerate it or bacteria are resistant. INH is bactericidal for multiplying tubercle bacilli, but is less effective agains ...
Emotional Inertia - Chapman University Digital Commons
... change at the same rate, i.e., change does not follow the negatively accelerated curve predicted by the dose-effect model. Patients needing fewer therapy sessions improved more quickly than patients requiring more sessions. Bornas, Gelabert, Llabrés, Balle, and Tortella-Feliu (2011) reported similar ...
... change at the same rate, i.e., change does not follow the negatively accelerated curve predicted by the dose-effect model. Patients needing fewer therapy sessions improved more quickly than patients requiring more sessions. Bornas, Gelabert, Llabrés, Balle, and Tortella-Feliu (2011) reported similar ...
Hysone
... The use of Hysone in the treatment of conditions other than those specified in the Indications section is not advised, due to the marked effect of hydrocortisone on sodium retention. Corticosteroids may mask some signs of infection, and new infections may appear during their use. There may be decrea ...
... The use of Hysone in the treatment of conditions other than those specified in the Indications section is not advised, due to the marked effect of hydrocortisone on sodium retention. Corticosteroids may mask some signs of infection, and new infections may appear during their use. There may be decrea ...
ABC`s Of Hepatitis C Treatment Readiness and Follow-up
... 2010. Abstract 216. 4. These data are available in press release format only, have not been peer reviewed, may be incomplete, and we await presentation or publication in a peer-reviewed format before conclusions should be made from these data. ...
... 2010. Abstract 216. 4. These data are available in press release format only, have not been peer reviewed, may be incomplete, and we await presentation or publication in a peer-reviewed format before conclusions should be made from these data. ...
once daily for 15 mg/kg/daily in bid
... retrospective analysis of medical records of 42 infants (21 in each group) with infantile spasms and hypsarrhythmia treated at the Universite de Montreal, Hopital Sainte-Justine, Montreal, Canada. Seizure response was similar in the ACTH and vigabatrin-treated infants at 12 month follow-up (61% vs 7 ...
... retrospective analysis of medical records of 42 infants (21 in each group) with infantile spasms and hypsarrhythmia treated at the Universite de Montreal, Hopital Sainte-Justine, Montreal, Canada. Seizure response was similar in the ACTH and vigabatrin-treated infants at 12 month follow-up (61% vs 7 ...
Managing the Treatment
... New onset diabetes mellitus, exacerbation of pre-existing diabetes mellitus and hyperglycemia have been reported during post-marketing surveillance in HIVinfected patients receiving protease inhibitor therapy. Some patients required either initiation or dose adjustments of insulin or oral hypoglycem ...
... New onset diabetes mellitus, exacerbation of pre-existing diabetes mellitus and hyperglycemia have been reported during post-marketing surveillance in HIVinfected patients receiving protease inhibitor therapy. Some patients required either initiation or dose adjustments of insulin or oral hypoglycem ...
Amber star information sheet - March 2015 - Surrey PAD
... hypothyroidism; sinus bradycardia and sino-atrial heart block, combined use with drugs that may induce torsades de pointes (see Drug Interactions below), pregnancy (except in exceptional circumstances) and breast feeding. In patients with severe conduction disturbances or sinus node disease, amiodar ...
... hypothyroidism; sinus bradycardia and sino-atrial heart block, combined use with drugs that may induce torsades de pointes (see Drug Interactions below), pregnancy (except in exceptional circumstances) and breast feeding. In patients with severe conduction disturbances or sinus node disease, amiodar ...
see p. Psy15 - Viktor`s Notes for the Neurosurgery Resident
... onset of mood-elevation is slow (requires 2-4 weeks); initial treatment period is typically 4-8 weeks → dosage is gradually reduced unless relapse occurs. TCAs do not produce CNS stimulation or mood elevation in normal individuals (may produce sleepiness). TCAs can be used for prolonged treatm ...
... onset of mood-elevation is slow (requires 2-4 weeks); initial treatment period is typically 4-8 weeks → dosage is gradually reduced unless relapse occurs. TCAs do not produce CNS stimulation or mood elevation in normal individuals (may produce sleepiness). TCAs can be used for prolonged treatm ...
University of Cincinnati/Health Alliance Reynolds Geriatric
... Is there one medication that could be prescribed to treat two conditions? ...
... Is there one medication that could be prescribed to treat two conditions? ...
2013 AAHA/AAFP Fluid Therapy Guidelines for Dogs and Cats*
... diabetic ketoacidosis; K potassium; KCl potassium chloride; LRS lactated Ringer’s solution *This document is intended as a guideline only. Evidence-based support for specific recommendations has been cited whenever possible and appropriate. Other recommendations are based on practical clinical exper ...
... diabetic ketoacidosis; K potassium; KCl potassium chloride; LRS lactated Ringer’s solution *This document is intended as a guideline only. Evidence-based support for specific recommendations has been cited whenever possible and appropriate. Other recommendations are based on practical clinical exper ...
diphenoxylate/atropine (dye-fen-ox-i-late/a-troe-peen
... disease; Geriatric patients (more sensitive to effects); Children (more sensitive to effects, especially Down syndrome patients); Prostatic hyperplasia; Pregnancy, lactation, or children ⬍12 yr (safety not established for difenoxin/atropine in children ⬍12 yr; diphenoxylate/atropine should not be us ...
... disease; Geriatric patients (more sensitive to effects); Children (more sensitive to effects, especially Down syndrome patients); Prostatic hyperplasia; Pregnancy, lactation, or children ⬍12 yr (safety not established for difenoxin/atropine in children ⬍12 yr; diphenoxylate/atropine should not be us ...
Utilisation et l`intérêt clinique des anticorps monoclonaux
... prospects for its acceptance? Favas C, Isenberg DA. Nat Rev Rheumatol. 2009 Dec;5(12):711-6. ...
... prospects for its acceptance? Favas C, Isenberg DA. Nat Rev Rheumatol. 2009 Dec;5(12):711-6. ...
- intjmedsc
... outcome measures were child-reported symptoms of PTSD and depression, parent-reported psychosocial dysfunction and teacher-reported classroom problems. The instruments used were Child PTSD symptom scale, Child depression inventory, Pediatric symptom checklist and Teacher-Child rating scale. The stud ...
... outcome measures were child-reported symptoms of PTSD and depression, parent-reported psychosocial dysfunction and teacher-reported classroom problems. The instruments used were Child PTSD symptom scale, Child depression inventory, Pediatric symptom checklist and Teacher-Child rating scale. The stud ...
Stratified medicine
... indicate that a given patient is likely to show a response to the therapy. Some call this approach of proactively testing and selecting populations for specific treatments ‘personalized’ medicine, but we believe a more useful description is ‘stratified’ medicine. In stratified medicine, a patient ca ...
... indicate that a given patient is likely to show a response to the therapy. Some call this approach of proactively testing and selecting populations for specific treatments ‘personalized’ medicine, but we believe a more useful description is ‘stratified’ medicine. In stratified medicine, a patient ca ...
QA168_7Renal replacement therapiesOct15 final
... RRT technologies and practices have evolved significantly in recent years. In most cases, these have resulted in greater drug clearances. Pharmacokinetic studies that formed the basis for many of the drug dosing recommendations used today were performed in the 1980s and 1990s using RRT techniques su ...
... RRT technologies and practices have evolved significantly in recent years. In most cases, these have resulted in greater drug clearances. Pharmacokinetic studies that formed the basis for many of the drug dosing recommendations used today were performed in the 1980s and 1990s using RRT techniques su ...
Vol 12, Nbr 2 - International Journal of Pharmaceutical Compounding
... - Estriol - Estrone - Progesterone - Testosterone • The term “natural” may have two different meanings when applied to BHRT: (1) they occur naturally in the body; (2) many of them are derived from plant (soy and yam) materials initially and then synthesized into the pure chemical United States Pharm ...
... - Estriol - Estrone - Progesterone - Testosterone • The term “natural” may have two different meanings when applied to BHRT: (1) they occur naturally in the body; (2) many of them are derived from plant (soy and yam) materials initially and then synthesized into the pure chemical United States Pharm ...
OT/PT TR BESt Interactive Metronome
... whether or not these improvements will transfer to other activities. In the literature, the IM program has been reported to produce changes in the areas of motor control, timing and rhythm, and visual-motor control (Taub 2007 [2b], Shaffer 2001 [2b], Cosper 2009 [4b], Burpee 2001 [5b]). Specific sub ...
... whether or not these improvements will transfer to other activities. In the literature, the IM program has been reported to produce changes in the areas of motor control, timing and rhythm, and visual-motor control (Taub 2007 [2b], Shaffer 2001 [2b], Cosper 2009 [4b], Burpee 2001 [5b]). Specific sub ...
Significance of syncope in patients with Alzheimer`s disease treated
... inducing syncope during tilt-table testing[16]. In patients 2 and 3, bradyarrhythmias observed during hospitalization strongly suggested a relationship with the episodes of syncope that had occurred out of the hospital. The absence of recurrence of syncope after pacemaker insertion during a follow-u ...
... inducing syncope during tilt-table testing[16]. In patients 2 and 3, bradyarrhythmias observed during hospitalization strongly suggested a relationship with the episodes of syncope that had occurred out of the hospital. The absence of recurrence of syncope after pacemaker insertion during a follow-u ...
CFS/ME Therapy Good Practice Guide
... Treating clinicians should satisfy themselves that the particular symptom they are going to treat is attributable to CFS/ME and that no other condition requiring definitive treatment is likely to co-exist. Even when a diagnosis of CFS/ME has been well established, any new symptom needs careful evalu ...
... Treating clinicians should satisfy themselves that the particular symptom they are going to treat is attributable to CFS/ME and that no other condition requiring definitive treatment is likely to co-exist. Even when a diagnosis of CFS/ME has been well established, any new symptom needs careful evalu ...
Therapy and Symptom Management in CFS/ME.
... Treating clinicians should satisfy themselves that the particular symptom they are going to treat is attributable to CFS/ME and that no other condition requiring definitive treatment is likely to co-exist. Even when a diagnosis of CFS/ME has been well established, any new symptom needs careful evalu ...
... Treating clinicians should satisfy themselves that the particular symptom they are going to treat is attributable to CFS/ME and that no other condition requiring definitive treatment is likely to co-exist. Even when a diagnosis of CFS/ME has been well established, any new symptom needs careful evalu ...
SINTROM®
... There are many possible interactions between coumarins and other drugs. The mechanisms of these interactions include disturbances of absorption, inhibition or induction of the metabolising enzyme system (mainly CYP2C9, see section 5.2 Pharmacokinetic properties), and reduced availability of the vita ...
... There are many possible interactions between coumarins and other drugs. The mechanisms of these interactions include disturbances of absorption, inhibition or induction of the metabolising enzyme system (mainly CYP2C9, see section 5.2 Pharmacokinetic properties), and reduced availability of the vita ...
Slajd 1 - Zakład Farmakologii Klinicznej w Poznaniu
... Recommendation: the use of low-dose ASA for cardioprophylaxis is associated with a 2-4 – fold increase in UGIE. Enteric-coated preparations do not reduce the risk of bleeding. For patients at risk of adverse events, gastroprotection should be prescribed. The risk of UGIE increases with dose of ASA; ...
... Recommendation: the use of low-dose ASA for cardioprophylaxis is associated with a 2-4 – fold increase in UGIE. Enteric-coated preparations do not reduce the risk of bleeding. For patients at risk of adverse events, gastroprotection should be prescribed. The risk of UGIE increases with dose of ASA; ...